These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Stopping medical research to save money: a broken pact with researchers and patients. Psaty BM; Rennie D JAMA; 2003 Apr 23-30; 289(16):2128-31. PubMed ID: 12709471 [No Abstract] [Full Text] [Related]
65. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions. Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA; Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536 [TBL] [Abstract][Full Text] [Related]
66. Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients. Konrad T; Franke S; Schneider F; Bär F; Vetter G; Winkler K J Hum Hypertens; 2011 Jan; 25(1):18-24. PubMed ID: 20237501 [TBL] [Abstract][Full Text] [Related]
67. Thiazide diuretics and β-blockers in the treatment of hypertension in diabetes mellitus. Sander GE; Giles TD J Clin Hypertens (Greenwich); 2011 Apr; 13(4):296-300. PubMed ID: 21466629 [No Abstract] [Full Text] [Related]
68. Dihydropyridines and beta-adrenoceptor antagonists as combination treatment in hypertension. MacCarthy EP J Hypertens Suppl; 1987 Dec; 5(4):S133-7. PubMed ID: 2894418 [TBL] [Abstract][Full Text] [Related]
69. Angiotensin receptor blocker and calcium channel blocker combination prevents cardiovascular events in CKD better than high-dose ARB alone. Woo KT; Wong KS; Choong HL; Foo MW; Tan HK; Chan CM Kidney Int; 2013 Jul; 84(1):214-5. PubMed ID: 23812366 [No Abstract] [Full Text] [Related]
72. Awaiting the OSCAR subanalysis of subjects according to the presence of proteinuria. Fukuda M; Miura T Kidney Int; 2013 Nov; 84(5):1047. PubMed ID: 24172734 [No Abstract] [Full Text] [Related]
74. Pharmacological engineering of endothelial function and vessel response to drug-eluting stents: do-it-yourself with calcium-channel and angiotensin-receptor blockers. Sangiorgi G; Biondi-Zoccai G Circ J; 2010 Aug; 74(8):1536-7. PubMed ID: 20647636 [No Abstract] [Full Text] [Related]
76. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial. Matsuzaki M; Ogihara T; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Abe K; Suzuki N; Eto T; Higaki J; Ito S; Kamiya A; Kikuchi K; Suzuki H; Tei C; Ohashi Y; Saruta T; J Hypertens; 2011 Aug; 29(8):1649-59. PubMed ID: 21610513 [TBL] [Abstract][Full Text] [Related]
77. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial. Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T; Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623 [TBL] [Abstract][Full Text] [Related]
78. A compendium of antihypertensive therapy. Ferdinand KC J Clin Hypertens (Greenwich); 2011 Sep; 13(9):636-8. PubMed ID: 21896141 [No Abstract] [Full Text] [Related]
79. Is there an optimal combination of antihypertensives for preventing cardiovascular events? Teo KK J Hypertens; 2011 Aug; 29(8):1483-5. PubMed ID: 21750437 [No Abstract] [Full Text] [Related]